Topic: Addictive Disorders

« Back

Print this page

	Personalized Program The Personalized Program enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log in to use the Personalized Program.	» Login » Identification » Help

	Sunday, 28. June 2009	next day »

No.	TG-01 - WFSBP Treatment Guidelines
Time:	11.00-12.30
Room:	Room 242A
Topic:	Addictive Disorders
Session title:	Addiction
	Saroja Krishnaswamy, Malaysia	Chair

	David A. Gorelick, USA	Presenter
	Michel Lejoyeux, France	Presenter

No.	FC-04 - Free Communications
Time:	12.30-14.00
Room:	Room 351
Topic:	Addictive Disorders
Session title:	Addictive Disorders I
	Saroja Krishnaswamy, Malaysia	Chair
	N N	Co-Chair

001	Clinical characteristics of patients with cannabis dependence
	Alain Dervaux, France	Speaker
002	Attention Deficit Hyperactivity Disorder (ADHD) among cocaine / crack abusers: Descriptive study in Martinique (French West Indies)
	Héloise Delavenne, France	Speaker
003	Cortical inhibition in alcohol dependence - examination with the double-pulse transcranial magnetic stimulation
	Martin Pitterl, Switzerland	Speaker
004	Difference in reflection-impulsivity between pathological gamblers and healthy controls
	Pinhas Dannon, Israel	Speaker
006	Changes in Cerebral type 1 Cannabinoid Receptor (CB1-R) availability in Ethanol-dependent patients after binge drinking and abstinence
	Titia Hompes, Belgium	Speaker

No.	P-01 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Addictive Disorders
Session title:	Addictive Disorders I
	Amine Benyamina, France	Chair

001	Investigation of ventromedial prefrontal cortex associated decision-making skills at the beginning of abstinence in alcohol addicted patients
	Bálint Andó, Hungary	Presenter
002	Attentional bias associated with cocaine cues: Differences among cocaine dependents, occasional cocaine users and controls
	Gabriel Rubio, Spain	Presenter
003	Neurofeedback for treating substance use disorders: A review
	Anja Neumann-Thiele, Germany	Presenter
004	Experience of Gabapentin (Tebantin®) application for treatment of alcohol cancellation in intact condition
	Aleksandr Kim, Kazakhstan	Presenter
005	Inhibition of anandamide hydrolysis reduces reinstatement of nicotine seeking but not motivation for nicotine - Comparison with CB1 receptor blockade
	Benoit Forget, Canada	Presenter
007	Tobacco smoking and motivation to quit in psychiatric patients
	Eva Gonçalves, Portugal	Presenter
008	Cocaine induced psychotic symptoms in a French sample of cocaine addicts
	Florence Vorspan, France	Presenter
009	Assessment of denial and insight in patients with nicotine and alcohol dependence
	Florence Vorspan, France	Presenter
010	Adaptation of the MOPS (Measurement of Parental Styles) in French: Preliminary results in drug dependant outpatients
	Florence Vorspan, France	Presenter
011	Alcohol use end anxious depressive disorders
	Alexandru Tiugan, Romania	Presenter
012	Differential characteristics between substance - induced and primary psychotic disorders
	Gerard Mateu Codina, Spain	Presenter
013	A flow-cytometric and electron - microscopic study of the combined effect of human immunodeficiency virus (HIV)-1 Tat and methamphetamine on the human neuroblastoma cell line SH-SY5Y
	Li Qi, China, People's Republic of :	Presenter
014	Drug addiction among schizophrenic inpatients
	Radhouene Kachouri, Tunisia	Presenter
015	Personality characters as a predictor of tendency to addiction
	Gholam Ali Nikpour, Iran	Presenter
016	The role of the relationship between therapist and patient in an individual outpatient program for drug addiction treatment by the administration of naltrexone
	Lygeri Iliopoulou, Greece	Presenter
017	Effects of microwave resonance therapy on oxidative modification of proteins and lipids of blood plasma and erythrocyte in alcoholism
	Valentina Prokopyeva, Russia	Presenter
018	Factors associated with relapse of drug addiction among males in Selangor, Malaysia
	Mas Ayu Said, Malaysia	Presenter
019	Event-related potential subsequent memory effect dysfunction in chronic cannabis users
	Robert Battisti, Australia	Presenter
020	Visuospatial memory deficits, subclinical psychotic symptoms and structural brain changes in long term heavy cannabis users
	Robert Battisti, Australia	Presenter
021	The effect of 3,4-Methylendioxymetamphetamine (MDMA) on proliferation and survival of neurons in hippocampus in adult rats
	Martina Kutová, Czech Republic	Presenter

No.	S-23 - Symposium
Time:	16.00-17.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	3 Interface
Session title:	Are first experiences with alcohol predicting later risk of alcohol-dependence? Clinical and biological approaches
	Pierre-Marie Llorca, France	Chair
	Wei J. Chenb, Taiwan	Co-Chair

001	Alcohol consumption and dependence: A study of medical students
	Sami Richa, Lebanon	Speaker
002	Early alcohol experiences and adolescent mental health: A population-based study in Taiwan
	Wei J. Chenb, Taiwan	Speaker
003	Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories
	Warner La, USA	Speaker

« previous day	Monday, 29. June 2009	next day »

No.	S-35 - Symposium
Time:	11.00-12.30
Room:	Room 241
Topic:	Addictive Disorders
Track:	3 Interface
Session title:	Behavioral addictions: Neurobiology and treatment
	David A. Gorelick, USA	Chair
	Aviv Weinstein, Israel	Co-Chair

001	The neuropsychopharmacology of pathological gambling
	Marc Potenza, USA	Speaker
002	Compulsive buying
	Michel Lejoyeux, France	Speaker
003	Sexual addiction and paraphilias
	Florence Thibaut, France	Speaker
004	Dopamine release during computer game playing
	Aviv Weinstein, Israel	Speaker

No.	P-12 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Addictive Disorders
Session title:	Addictive Disorders II
	Franck Bayle, France	Chair

001	Smoking is associated with psychosis
	Renaud de Beaurepaire, France	Presenter
002	Concurrent disorders: Substance use disorders, eating disorders, and post-traumatic stress disorders
	Christine Courbasson, Canada	Presenter
004	Influence of acute hemoexfusion on severity and length of withdrawal syndrome in heroin addiction
	E. N. Krivulin, Russia	Presenter
005	Cigarettes smoking, lipid profile and paraoxonase 1 activity
	Haj Mouhamed Dhouha, Tunisia	Presenter
006	Psychopharmacotherapy of pathological gambling comorbid with affective disorder
	D. Chetverikov, Russia	Presenter
007	Assessing the psychometric properties of the 6th Brazilian version of the Addiction Severity Index (ASI 6): Family-social area
	Laisa Sartes, Brazil	Presenter
008	Common pathogenetic mechanisms of alcoholic and food addiction
	Marina Chukhrova, Russia	Presenter
009	Naltrexone for the treatment of amphetamine dependence: A randomized placebo controlled trial
	Nitya Jayaram-Lindström, Sweden	Presenter
013	Treatment of sleep disturbances in the alcohol dependence - comparative effects of Zolpidem vs. Benzodiazepines hypnotics
	Meri Jakovcevska-Kujundziska, Macedonia, The former Yugoslav	Presenter
014	Differences in use of wait-and-see strategy in the stop signal task between non-chemical and chemical addictions
	Pinhas Dannon, Israel	Presenter
015	Sensitivity of the dopaminergic neurotransmision to opioidergic stimulation in alcoholism: A PET study with [18F] fallypride
	Michael Paulzen, Germany	Presenter
016	Impairment in the prepulse inhibition (PPI) in abstinent alcoholics
	Gabriel Rubio, Spain	Presenter
017	Considerations about the influence of age and duration of opiate use on the condition and symptoms of opiate addicts
	Peter Hermann, Austria	Presenter
018	Epidemiological characteristics of clinicaly treated heroin addicts
	Abdurahman Kuldija, Bosnia and Herzegovina	Presenter
019	Addictive disorder
	Adebowale Yusuf Adedoja, Nigeria	Presenter
020	Effects of methadone therapy on changing of positive and negative mood affect in addicted
	Seyed Jalal Mosavi Amiri, Iran	Presenter
021	What is the first cause of tendency to addiction? Psychological, environmental or physical
	Seyed Jalal Mosavi Amiri, Iran	Presenter

« previous day	Tuesday, 30. June 2009	next day »

No.	S-46 - Symposium
Time:	08.00-09.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	1 Basic
Session title:	Dysregulation of neurogenesis in the brain action: The common mechanism of alcoholism and depression
	Toshikazu Saito, Japan	Chair
	Stefan Brene, Sweden	Co-Chair

001	Stem cells and alcohol dependence: Suppressed neurogenesis after long periods of abstinence
	Anita C. Hansson, Germany	Speaker
002	Depending on dose and context, alcohol consumption can both increase and decrease hippocampal neurogenesis in rodents
	Stefan Brene, Sweden	Speaker
003	Effects of chronic ethanol exposure on long-term differentiation of SH-SY5Y human neuroblastoma cells
	Julian D. Hellmann, Germany	Speaker
004	Potential regulation of neurogenesis by psychotropics in the damaged brain by ethanol
	Eri Hashimoto, Japan	Speaker

No.	PL-03 - Plenary Lecture
Time:	09.45-10.30
Room:	Main Amphitheatre
Topic:	Addictive Disorders
Session title:	Addiction and the neurobiology of choice and self-control
	Siegfried Kasper, Austria	Chair

001	Addiction and the neurobiology of choice and self-control
	Nora Volkow, USA	Speaker

No.	S-51 - Symposium
Time:	11.00-12.30
Room:	Room 252B
Topic:	Addictive Disorders
Track:	2 Clinical
Session title:	Cannabis: What's happening?
	Amine Benyamina, France	Chair
	Michel Reynaud, France	Co-Chair

001	Pharmacological treatment of cannabis dependence
	Margaret Haney, USA	Speaker
002	Cannabis and psychiatric co-morbidity
	Stanley Zammit, United Kingdom	Speaker
003	Cannabis: Legal aspects and decriminalisation
	Wim van den Brink, Netherlands	Speaker
004	Pharmacogenetic vulnerability
	Amine Benyamina, France	Speaker

« previous day	Wednesday, 1. July 2009	next day »

No.	S-64 - Symposium
Time:	08.00-09.30
Room:	Room 241
Topic:	Addictive Disorders
Track:	1 Basic
Session title:	Brain imaging in addiction
	David A. Gorelick, USA	Chair
	Aviv Weinstein, Israel	Co-Chair

001	Role of dopamine in human drug self-administration
	Marco Leyton, Canada	Speaker
002	Role of brain mu-opioid receptors in cocaine addiction
	David A. Gorelick, USA	Speaker
003	Brain serotonin function in MDMA (ecstasy) users
	Franz Vollenweider, Switzerland	Speaker
004	Brain imaging studies of cognitive effects of recreational drugs
	Aviv Weinstein, Israel	Speaker

No.	P-32 - Poster Presentation
Time:	12.30-14.00
Room:	Foyer
Topic:	Addictive Disorders
Session title:	Addictive Disorders III
	Aviv Weinstein, Israel	Chair

001	Pain, personality and addiction: Pain coping strategies related to personality traits in substance abusers
	Alireza Homayouni, Iran	Presenter
002	Personality and tendency to addiction: Comparison between addicts and nonaddicts
	Alireza Homayouni, Iran	Presenter
003	Family burden in alcohol dependence
	Elias Tzavellas, Greece	Presenter
004	Tiagabine in the management of collateral psychopathology during alcohol detoxification
	Elias Tzavellas, Greece	Presenter
005	Personality of polysubstance abusers with the acute psychotic episode
	Milan Zdravkovic, Serbia and Montenegro	Presenter
006	Apoptosis of immune competent cells in alcoholic patients
	Nikolay Bokhan, Russia	Presenter
007	Alcoholism, comunication and family
	Paula Santos, Portugal	Presenter
008	Correlates of lifetime alcohol misuse among older community residents in Brazil
	Sergio Blay, Brazil	Presenter
009	The influence of alcohol metabolizng enzymes and their combinations on drinking behaviors of Korean young adults
	Sie-Kyeong Kim, Korea, Republic of	Presenter
010	Serotonin 5-HT2B receptors are required for MDMA-induced hyperlocomotion, locomotor sensitization, CPP and serotonin release in vivo
	Stephane Doly, France	Presenter
011	Steroid hormones and aggression in alcohol dependent patients in the conditions of social isolation
	Svetlana Ivanova, Russia	Presenter
012	Trazadone in the treatment of insomnia in patients on methadone maintenance
	Milica Nikic, Serbia and Montenegro	Presenter
013	Alcohol modulates the properties of benzodiazepine receptors peripheral type
	Tamara Shushpanova, Russia	Presenter
015	Low self-esteem as a risk factor for alcohol abuse in undergraduate students
	Veronica Ituarte, Mexico	Presenter
016	Variability of the human MPDZ gene sequence and association with alcoholism
	Victor Karpyak, USA	Presenter
017	Paroxetine compared to Alprazolam in the treatment of alcohol dependence
	Vilma Lazarova, Macedonia, The former Yugoslav	Presenter
018	Dopamine partial agonist effect on the craving for smoking in patients with schizophrenia
	Young-Sik Lee, Korea, Republic of	Presenter
019	Psychiatric comorbidity of internet addiction in Romanian teenagers: An observational study
	Cristinel Stefanescu, Romania	Presenter

« previous day	Thursday, 2. July 2009

No.	FC-35 - Free Communications
Time:	12.30-14.00
Room:	Room 242A
Topic:	Addictive Disorders
Session title:	Addictive Disorders II
	Franck Bayle, France	Chair
	Saroja Krishnaswamy, Malaysia	Co-Chair

001	Blaming Parkinson's for addiction?
	Ingrid de Chazeron, France	Speaker
002	Treating social anxiety disorder effectively in patients with substance use disorders
	Christine Courbasson, Canada	Speaker
004	The intergenerational transmission of tobacco smoking - the role of parents’ long-term smoking trajectories
	Maria Melchior, France	Speaker
005	Automatized action schemata in nicotine dependence: Evidence from functional magnetic resonance imaging and a behavioral affordance paradigm
	Yavor Yalachkov, Germany	Speaker
006	Developmental changes in P300 amplitude and risk for substance use disorder
	Miguel Habeych, USA	Speaker

« Back

---